A 41-year-old transgender man with HIV was diagnosed with HIV and Pneumocystis pneumonia 9 months ago. He is seen in clinic for a follow-up visit. At the time of the HIV diagnosis, the CD4 count was 118 cells/mm3 and the HIV RNA level was 108,700 copies/mL. He started antiretroviral therapy shortly after his Pneumocystis pneumonia diagnosis, and he now has a CD4 count of 257 cells/mm3 and an undetectable HIV RNA level. Three months prior, the CD4 count was 211 cells/mm3 and the HIV RNA level was undetectable. In addition to antiretroviral medications, he is taking trimethoprim-sulfamethoxazole as secondary prophylaxis for Pneumocystis pneumonia.
Which one of the following is considered a recommended indication for discontinuing Pneumocystis pneumonia secondary prophylaxis?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 28th, 2023
September 28th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5